Projects Showing 1 - 11 out of 11 results Filter by Program - Any -Aboriginal and Torres Strait Islander Health ProgramBiosecurity ProgramBiostatistics and Databases ProgramGlobal Health ProgramHIV Epidemiology and Prevention ProgramImmunovirology and Pathogenesis ProgramInfection Analytics ProgramSexual Health ProgramSurveillance and Evaluation Research ProgramTherapeutic and Vaccine Research ProgramViral Hepatitis Clinical Research ProgramViral Hepatitis Epidemiology and Prevention ProgramViral Immunology Systems Program Keywords Focus areas - Any -Aboriginal and Torres Strait Islander healthCOVID-19 and emerging infectionsGlobal healthHIVHPVSexual healthViral hepatitis Research strengths - Any -Biostatistics, modelling and analysisCapacity buildingClinical trials and cohortsEpidemiology and surveillanceHealth economics and health systemsImmunovirologyNew diagnostic approachesPublic health interventionsSocial and behavioural sciences View more Sort by Earliest firstLatest firstTitle A - ZTitle Z - A Gene delivery Contribution of T follicular helper cells to recrudescence from the latent HIV-1 reservoir SiRNA Project Harnessing antibodies to treat COVID-19 Engineering monoclonal antibodies for COVID-19 protection and therapy Development of antiviral RNA therapeutics for COVID-19 treatment delivered via nanoparticle inhalation Natural history cohort following SARS-CoV-2 infection Evolution of HIV Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy The CIRCUIT Study BRIDGE (Bringing RNA Innovations through the Developmental Gap Effectively) Invitation for Expression of Interest The BRIDGE consortium is extending an invitation for expressions of interest (EOI) pertaining to RNA-based candidates with the potential to significantly contribute to the prevention of SARS-CoV-2 infection, and the treatment of COV
Development of antiviral RNA therapeutics for COVID-19 treatment delivered via nanoparticle inhalation
Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy
BRIDGE (Bringing RNA Innovations through the Developmental Gap Effectively) Invitation for Expression of Interest The BRIDGE consortium is extending an invitation for expressions of interest (EOI) pertaining to RNA-based candidates with the potential to significantly contribute to the prevention of SARS-CoV-2 infection, and the treatment of COV
